Javascript is disabled in your browser

Startbase requires Javascript in order to display content.
Please check your browser settings and enable Javascript-Support for this website.

Biotech

News Infinite Roots receives 58 million US dollars Biotech company Infinite Roots receives financial injection from industry leaders to further develop mushroom mycelium technologies.

Marc Nemitz 25.01.2024

News X2.0 opens the 3rd Open Call for HealthTech and BioTech Startups X2.0 announces the ten selected AgriTech startups of the current funding and launches 3rd Open Call for HealthTech and BioTech. Sustainable innovations will be supported. Application deadline until Sept. 5.

Marc Nemitz 30.08.2023

News Financing boom for German biotechs The industry was able to collect around 2.3 billion euros last year. That is almost a record.

Janina Gerhardt 20.01.2022

Interviews Startup of the month Prevention instead of just treating the symptoms The intestinal flora is a term that many would prefer never to talk about. Yet it has a massive influence on physical health. The founding team of Biomes wants to change that - and revolutionize the healthcare system...

Sophie Zeller 01.12.2021

News 64 million euros for Cardior The biotech company from Hanover is pleased about an oversubscribed Series B financing round. Now the start-up wants to push ahead with the development of its cardiac drug.

Lars-Thorben Niggehoff 25.08.2021

News Mk2 Biotechnologies closes seed financing deal The Munich-based start-up has raised several million euros in a seed financing round. In autumn, the company will move into a biotechnology incubator.

Lisa Marie Münster 02.08.2021

News Contact lens for the ear comes on the market Mannheim-based start-up Vibrosonic is launching its "hearing contact lens". The device is invisible and is supposed to be better than normal hearing aids.

Tom Schmidtgen 09.07.2021

News Atai receives 130 million euros With the current financing round, the biotech company Atai is said to be worth 1.7 billion euros. The round was led by German investor Christian Angermayer.

Lisa Marie Münster 04.03.2021

News Nine million euros for GeneQuine Biotherapeutics The money is to be used for the development of a gene therapy. The company already holds a European patent.

Tom Schmidtgen 28.01.2021

News Bayer leads Series B financing of Senti Bio Senti Bio receives 105 million US dollars. The financing round was led by Bayer. Senti Biosciences receives an investment of 105 million US dollars. Among the backers is Leaps by Bayer, the investment arm of Bayer AG....

Tom Schmidtgen 07.01.2021

1